Our findings have multiple translational implications and link SGLT2i to the ApoM/S1P pathway, which is inversely associated with mortality in COVID-19,27,47 sepsis,18,28, 29, 30 HF 25, and T2DM.18 The gene discussed is APOM; the disease is COVID-19.